STOCK TITAN

Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Quest Diagnostics Incorporated (NYSE: DGX) to Present at J.P. Morgan Healthcare Conference, Offering Insight into Company Strategy and Market Trends
Positive
  • None.
Negative
  • None.

SECAUCUS, N.J., Dec. 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance, and the latest market developments and trends during a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024, at 6:45 p.m. Eastern Time.

The fireside chat and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 8, 2024.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-42nd-annual-jp-morgan-healthcare-conference-302021216.html

SOURCE Quest Diagnostics

FAQ

What is the date and time of the fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference for Quest Diagnostics Incorporated (NYSE: DGX)?

The fireside chat will take place on Tuesday, January 9, 2024, at 6:45 p.m. Eastern Time.

Where can I access the live webcast of the fireside chat for Quest Diagnostics Incorporated (NYSE: DGX)?

The live webcast will be available on the company's investor relations page at ir.QuestDiagnostics.com.

When will the archived webcast of the fireside chat be available for Quest Diagnostics Incorporated (NYSE: DGX)?

The archived webcast will be available within 24 hours after the live event and will remain accessible until February 8, 2024.

Who will be speaking at the fireside chat for Quest Diagnostics Incorporated (NYSE: DGX) at the 42nd Annual J.P. Morgan Healthcare Conference?

Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will be speaking at the fireside chat.

What will be the focus of the fireside chat for Quest Diagnostics Incorporated (NYSE: DGX) at the 42nd Annual J.P. Morgan Healthcare Conference?

The focus will be on the company's strategy, performance, and the latest market developments and trends.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

15.15B
109.71M
0.43%
91.73%
2.29%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SECAUCUS

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator